Roundhill GLP-1 & Weight Loss ETF
OZEM
#2750
ETF Rang
€50.08 Mio.
Marktkapitalisierung
🇺🇸 US
Markt
29,99 €
Aktienkurs
0.16%
Veränderung (1 Tag)
24.59%
Veränderung (1 Jahr)

Roundhill GLP-1 & Weight Loss ETF - Bestände

ETF-Bestände zum Stand 17. Februar 2026

Anzahl der Bestände: 26

Vollständige Bestandsliste

Gewichtung %NameTickerGehaltene Aktien
18.49%
Novo Nordisk A/SNVO220680
14.93%
Eli Lilly & CoLLY8494
4.68%
Ascletis Pharma Inc1672 HK1319000
4.55%
Roche Holding AGROG SW5764
4.39%
Chugai Pharmaceutical Co Ltd4519 JP42900
4.37%
Hanmi Pharm Co Ltd128940 KS6223
4.26%
Pfizer IncPFE91429
3.95%
Structure Therapeutics IncGPCR33344
3.88%
Amgen IncAMGN6224
3.78%
Zealand Pharma A/SZEAL DC35303
3.50%
Innovent Biologics Inc1801 HK183000
3.50%
Viking Therapeutics IncVKTX71364
3.44%
AstraZeneca PLCAZN9894.5
3.21%
Shanghai Fosun Pharmaceutical Group Co Ltd2196 HK726000
2.83%
Regeneron Pharmaceuticals IncREGN2088
2.30%
Gilead Sciences IncGILD8763
2.22%
CSPC Pharmaceutical Group Ltd1093 HK1016000
2.10%
United Laboratories International Holdings Ltd/The3933 HK778000
1.94%
Scholar Rock Holding CorpSRRK24964
1.91%
Gubra A/SGUBRA DC18205
1.72%
Biohaven LtdBHVN89380
1.70%
Shionogi & Co Ltd4507 JP43600
1.29%
Rhythm Pharmaceuticals IncRYTM7782
0.71%
WaVe Life Sciences LtdWVE32904
0.23%
Cash & OtherCash&Other134758.2
0.12%
First American Government Obligations Fund 12/01/2031FGXXX73060.98